Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. - Wikidata - wikimedia - TriplyDB

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

http://www.wikidata.org/entity/Q35833921

about

Microbiota and Neurological Disorders: A Gut Feeling.Gastrointestinal stem cells in health and disease: from flies to humans Cytokine-Induced Modulation of Colorectal Cancer Drug Discovery via Human-Derived Stem Cell Organoids Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer High-content molecular profiling of T-cell therapy in oncology Implication of the intestinal microbiome in complications of cirrhosis Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome Role of the Microbiota in Colorectal Cancer: Updates on Microbial Associations and Therapeutic Implications Glutamine-Induced Secretion of Intestinal Secretory Immunoglobulin A: A Mechanistic Perspective PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment Gut microbiota and colorectal cancer.Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.The intestinal microbiome and surgical disease.Pharmacogenomics of off-target adverse drug reactions.Metagenomics and Single-Cell Omics Data Analysis for Human Microbiome Research.Immune Checkpoint in Glioblastoma: Promising and Challenging Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going?Role of CD152 genetic polymorphisms in the susceptibility to breast cancer.Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy.Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.Microbiota, Inflammation and Colorectal Cancer.Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: A pilot study.Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.Manipulation of Innate and Adaptive Immunity through Cancer Vaccines.The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy?Tumour immunology: Intestinal bacteria are in command.A 'fit' microbiota to potentiate cancer immunotherapy The role of microbiota in cancer therapy.Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes.Signaling in Host-Associated Microbial Communities.The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism Recognizing that the microbiome is part of the human immune system will advance treatment of both cancer and infections.The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.

P2860

Q24570085-18DCC151-14BF-4CC4-B482-05EB21B62346 Q26750514-ECE0729C-D55E-43B9-A26D-9EC9D7A29321 Q26752374-94203916-6126-491A-8E7A-30A57EF090EE Q28066424-9D27C34B-044E-4D5A-94CC-4FF820F05AE5 Q28066532-04869B4D-D5F3-4B8D-BE86-9F6B6F9A52B3 Q28066792-7C1BDC72-2EF0-452B-A49F-DCAE18CF0F1E Q28068832-B70102AA-4835-44D5-BF0B-16BBDB96F721 Q28069401-23BBFB1B-1294-429E-BE80-8F8D50B351F6 Q28069455-E9B511BF-29ED-4096-8CD9-EA0CBCDF7E75 Q28071938-115110E2-021C-4E3D-8A5F-6ABBED334C13 Q28073131-BF45A513-C231-41AF-8629-37D063D28EEF Q28073867-4283A1CB-726C-4610-808A-714A03D054DC Q28075712-271B073A-F363-4B14-B4EE-2E1B0E51E3F8 Q28076294-2FB23BDC-9A2E-414B-B16C-4C6B636264C7 Q30239806-069F89A3-DDA6-44EF-9A67-5CD13F39A42B Q30244608-CEDE158D-378B-471F-9F88-45FC23C79B5E Q30248605-B16E7BA4-514A-4C12-BF29-41A2FAF005CA Q30400366-46CDF7D6-8AFA-4079-8798-05400BA50E4B Q31140588-5D9C4571-BEDC-4E62-8427-9C60D0B2B043 Q33650058-E9253D33-ED88-4672-8049-AF6778A60366 Q33686153-044538C2-F5EF-4218-91AD-861EC6B59403 Q33688783-05B21D21-4E23-4E0E-8C10-E90EB3BA35C2 Q33699687-2C058A83-6BBE-4F55-9B58-62ACBA1381F6 Q33816141-9FEFA78E-C657-49C6-832D-0565344F323A Q33839116-D44B7FF2-3A00-4611-B0D2-8F4AF7CBFC51 Q33883909-00B500E1-06FB-4D38-A287-4852FE3CFCCF Q33918472-CD476DCA-DF89-490B-9788-93454B1E9BA3 Q34522172-D047412B-BCCA-46C0-9533-43B665F7ABCF Q34552791-850AFEE1-A866-43F7-A3FE-F91152FDA1C1 Q34553267-56CB1E6B-A165-417B-B122-2A68ACB4CF66 Q35854335-395FF7E0-27B8-41ED-8D27-3071FD1849E5 Q35865880-B0BBB153-F55C-4EA7-9359-91CDFF54A343 Q35874071-1749E122-101E-4869-9361-C5C2E5B61EBF Q35906938-767D3CCD-063A-4D01-97EA-DCE7601A31D9 Q35912366-CF507F6E-DA43-4E0D-A74D-9931E13682DA Q35947598-0C6ACB13-E7EE-47C0-AAF5-155EE1DAD405 Q35953810-830152FA-A552-45CD-B5DF-31DB7F9C2BB9 Q35955534-61145243-BECE-4867-9C25-FB7DB59B563A Q35958323-0C3276E8-E8FC-4135-8352-71A7F0F2574B Q36038992-9EEA0795-71A1-44C9-88B9-C2AB9ED72013

P2860

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

http://www.wikidata.org/entity/Q35833921

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

@ast

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

@en

type

label

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

@ast

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

@en

prefLabel

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

@ast

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

@en

P1433

Q35833921-D5E56CE3-16B5-4136-A8B6-8B88594621F1

P1476

Q35833921-86443462-9C0A-4B58-81A8-B566CD2D4B71

P2093

Q35833921-03ABAE57-6421-4776-B392-0EAB685E52EB

Q35833921-27064DE0-DAB4-4D31-92EC-8C610603583C

Q35833921-36F7821C-0E22-49C5-81A7-B2E9AE43F3B3

Q35833921-39850C47-43C1-45DF-85EC-8DF8BA942CAB

Q35833921-3AC3AEC7-A8CF-4F7F-AE13-8D10DC910AE9

Q35833921-426E6BED-B3EA-4391-BD44-3178185C2C44

Q35833921-6D033BC6-510E-4D5B-8644-50BEFAA9DFA9

Q35833921-707AF2BB-663B-491D-AF7A-DA86A5E47772

Q35833921-84AEA9A3-F8CA-4C85-83FC-BAAAA6A0350B

Q35833921-8920E6FF-2B5D-45F7-9429-54034AC363DE

P2860

Q35833921-1F44D4AC-F8F3-4AB8-8C08-C593E99D38B1

Q35833921-2EB7BB1A-C7CC-4644-A676-BFCCC4825568

Q35833921-2F7493B2-400C-43D4-9507-0C34BCF2880D

Q35833921-2FD3A495-4454-418E-8E70-B1A4B8DD7DC5

Q35833921-584394E3-75C3-4D86-B4DC-1F68AF3EBCEA

Q35833921-65945C13-7F0A-4F1C-AF75-7ADEE7122355

Q35833921-69D75C3D-3194-44AA-BA33-E7AD5F4E2A7A

Q35833921-6E8EB7AA-BDCC-4DE4-B8B2-C202E6E3E858

Q35833921-73A55EC8-DB63-414C-A541-E1D088377B72

Q35833921-7B6570D8-1BA4-49B2-8CDC-CB31850C782E

P304

Q35833921-A5F0BFB2-CD33-4594-A8DE-7DA8602C592A

P31

Q35833921-69F6BF1D-8730-4A7D-9134-9F69308DFCF2

P356

Q35833921-57463E40-68BB-4A41-8B6B-3C4DE24A2635

P407

Q35833921-F9F7579B-220F-46C4-A8A6-5EA6360608B7

P433

Q35833921-D5345BE4-0A11-4A2A-A064-43A8E5985936

P478

Q35833921-2A1696AD-2470-42DA-8ACD-BC894C65455A

P50

Q35833921-097F415C-A895-4F0C-A29C-7B1F6F6DC429

Q35833921-0BFF24C1-F8A7-4772-9AE5-B6800EA87437

Q35833921-10EACED4-52B6-4B7A-8BD6-A1F92FA524C0

Q35833921-12DDD9BF-07B0-40E1-A2FF-E5D2BD340170

Q35833921-1D565260-A0CE-41E0-8BE3-091119D6EA43

Q35833921-1DB2D1A2-B567-4B15-B7BA-5F6590446331

Q35833921-26EB3057-4BE4-4BA5-B640-E7634A9E3BB1

Q35833921-399ED9EB-6B49-4220-8E80-9D2831E2FDF0

Q35833921-400AFD72-5079-46F6-A670-5319EFA24768

Q35833921-4B791859-C099-478E-9976-2C3FE5DB635E

P577

Q35833921-CBE4DABF-CDE3-4FB5-BE18-8DDC11C8CF6D

P5875

Q35833921-B209454D-CA7E-4914-804F-647A68431F05

P698

Q35833921-4117CDED-DE08-49CA-B827-0A71ECC3182B

P921

Q35833921-BE5861BE-E938-401C-B057-67E22E1CF096

P932

Q35833921-95C733FA-8201-4ABF-AB66-383CE27DA45D

P356

SCIENCE.AAD1329

P1433

P1476

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

@en

P2093

Andreas Schlitzer

http://www.w3.org/2001/XMLSchema#string

Antoine Roux

http://www.w3.org/2001/XMLSchema#string

Bertrand Routy

http://www.w3.org/2001/XMLSchema#string

Christina Mateus

http://www.w3.org/2001/XMLSchema#string

Connie P M Duong

http://www.w3.org/2001/XMLSchema#string

David P Enot

http://www.w3.org/2001/XMLSchema#string

Elisabeth Chachaty

http://www.w3.org/2001/XMLSchema#string

Encouse Golden

http://www.w3.org/2001/XMLSchema#string

Florent Ginhoux

http://www.w3.org/2001/XMLSchema#string

Franck Carbonnel

http://www.w3.org/2001/XMLSchema#string

P2860

Enterotypes of the human gut microbiome

A human gut microbial gene catalogue established by metagenomic sequencing

Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.

Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms.

Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma.

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

The human commensal Bacteroides fragilis binds intestinal mucin

P304

1079-1084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.AAD1329

http://www.w3.org/2001/XMLSchema#string

P407

P433

6264

http://www.w3.org/2001/XMLSchema#string

P478

350

http://www.w3.org/2001/XMLSchema#string

P50

Laurence Zitvogel

Alexander Eggermont

Nathalie Chaput

Sylvie Rusakiewicz

Romain Daillère

Nicolas Jacquelot

Paul-Louis Woerther

Vichnou Poirier-Colame

P577

2015-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283515947

http://www.w3.org/2001/XMLSchema#string

P698

26541610

http://www.w3.org/2001/XMLSchema#string

P921

P932

4721659

http://www.w3.org/2001/XMLSchema#string